CA Stock MarketDetailed Quotes

HLS HLS Therapeutics Inc

Watchlist
  • 4.520
  • +0.100+2.26%
15min DelayMarket Closed Mar 27 16:00 ET
143.70MMarket Cap-5.07P/E (TTM)

HLS Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-49.31%8M
-14.17%3.21M
-72.03%1.5M
-5.58%2.52M
-80.65%778K
-6.81%15.79M
6.05%3.73M
29.29%5.37M
-24.03%2.67M
-30.18%4.02M
Net income from continuing operations
28.61%-19.66M
44.03%-3.02M
29.81%-4.84M
39.79%-5.68M
-5.42%-6.11M
-16.67%-27.53M
15.99%-5.4M
-56.49%-6.9M
-3.22%-9.44M
-60.18%-5.79M
Operating gains losses
---3.38M
--0
--0
----
----
----
----
----
----
----
Depreciation and amortization
-28.87%22.72M
-22.89%5.43M
-32.89%5.51M
-30.00%5.86M
-28.85%5.92M
-7.16%31.94M
-18.93%7.05M
-7.10%8.21M
-1.45%8.37M
-0.81%8.32M
Asset impairment expenditure
--0
--0
--0
----
----
27.60%3.89M
--1.54M
--0
----
----
Unrealized gains and losses of investment securities
-81.79%526K
101.14%3K
-99.11%18K
-44.21%318K
-66.06%187K
223.95%2.89M
-210.97%-263K
611.34%2.03M
181.90%570K
137.38%551K
Remuneration paid in stock
400.56%1.62M
170.38%423K
2,789.47%511K
211.68%427K
565.45%256K
-118.41%-538K
-179.92%-601K
-115.20%-19K
-88.86%137K
-106.75%-55K
Deferred tax
647.70%3.81M
-44.86%59K
91.31%-47K
4,642.35%3.86M
65.54%-61K
-604.35%-696K
212.63%107K
-176.02%-541K
-525.00%-85K
-143.28%-177K
Other non cashItems
53.83%1.23M
44.70%314K
77.39%353K
45.79%277K
47.64%282K
-1.60%797K
9.60%217K
-0.50%199K
-7.32%190K
-7.73%191K
Change In working capital
-77.35%1.14M
-100.46%-5K
-99.92%2K
46.61%843K
-69.38%301K
225.60%5.04M
554.82%1.09M
47,940.00%2.39M
61.52%575K
-4.56%983K
-Change in receivables
221.14%2.37M
998.64%2.43M
-207.54%-1.24M
120.34%346K
-21.33%837K
377.44%738K
128.96%221K
1,168.13%1.15M
-183.50%-1.7M
5.77%1.06M
-Change in inventory
71.41%-189K
-197.88%-1.83M
19.41%1.22M
70.83%1.19M
56.35%-770K
-6.27%-661K
-149.52%-613K
291.37%1.02M
138.77%696K
-476.92%-1.76M
-Change in payables and accrued expense
-294.94%-4.43M
-764.78%-3.66M
-46.13%842K
-286.16%-1.12M
-134.86%-495K
-27.72%2.27M
34.01%-423K
901.92%1.56M
-107.99%-289K
14,100.00%1.42M
-Change in other current assets
123.12%444K
-3.48%333K
279.35%588K
-126.59%-750K
810.00%273K
217.75%199K
131.54%345K
-46.37%155K
58.10%-331K
-83.61%30K
-Change in other working capital
18.19%2.94M
74.57%2.72M
6.33%-1.41M
-46.64%1.17M
95.71%456K
562.83%2.49M
750.82%1.56M
-18,650.00%-1.5M
2,994.74%2.2M
136.58%233K
Cash from discontinued investing activities
Operating cash flow
-49.31%8M
-14.17%3.21M
-72.03%1.5M
-5.58%2.52M
-80.65%778K
-6.81%15.79M
6.05%3.73M
29.29%5.37M
-24.03%2.67M
-30.18%4.02M
Investing cash flow
Cash flow from continuing investing activities
6,308.99%11.74M
7.14%-13K
-3,650.00%-1.5M
9,914.81%13.25M
-2K
98.14%-189K
30.00%-14K
99.60%-40K
-66.67%-135K
0
Net PPE purchase and sale
63.41%-15K
7.14%-13K
--0
--0
---2K
8.89%-41K
-55.56%-14K
--0
-80.00%-27K
--0
Net intangibles purchas and sale
9,052.70%13.25M
--0
--0
----
----
98.54%-148K
--0
99.60%-40K
----
----
Net business purchase and sale
---1.5M
--0
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
6,308.99%11.74M
7.14%-13K
-3,650.00%-1.5M
9,914.81%13.25M
---2K
98.14%-189K
30.00%-14K
99.60%-40K
-66.67%-135K
--0
Financing cash flow
Cash flow from continuing financing activities
-59.60%-23.36M
31.70%-2.65M
-251.81%-15.1M
12.48%-2.58M
13.66%-3.03M
-113.52%-14.64M
5.08%-3.89M
-167.77%-4.29M
38.54%-2.95M
18.22%-3.51M
Net issuance payments of debt
-127.97%-21.57M
19.72%-2.65M
-548.45%-15.1M
-3.75%-1.61M
2.80%-2.22M
-2,045.80%-9.46M
-29.60%-3.31M
-127.55%-2.33M
51.35%-1.55M
27.76%-2.28M
Net common stock issuance
61.34%-600K
--0
--0
-71.35%-317K
-53.80%-283K
-55.51%-1.55M
-65.71%-580K
-123.33%-603K
48.18%-185K
-776.19%-184K
Cash dividends paid
--0
--0
--0
--0
--0
51.67%-2.4M
--0
--0
4.03%-1.22M
7.80%-1.18M
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
-27.17%134K
--0
--0
--0
-18.79%134K
Net other financing activities
12.43%-1.19M
--0
--0
---658K
---533K
-112.83%-1.36M
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
-59.60%-23.36M
31.70%-2.65M
-251.81%-15.1M
12.48%-2.58M
13.66%-3.03M
-113.52%-14.64M
5.08%-3.89M
-167.77%-4.29M
38.54%-2.95M
18.22%-3.51M
Net cash flow
Beginning cash position
5.93%21.95M
-19.57%17.54M
55.34%32.52M
-8.35%19.44M
5.93%21.95M
-2.15%20.72M
2.49%21.81M
-1.08%20.93M
-6.40%21.21M
-2.15%20.72M
Current changes in cash
-477.32%-3.63M
424.10%538K
-1,557.05%-15.1M
3,278.07%13.19M
-546.25%-2.26M
1,650.00%961K
72.01%-166K
119.96%1.04M
69.62%-415K
-64.52%506K
Effect of exchange rate changes
-424.63%-870K
-300.65%-622K
175.00%120K
-187.97%-117K
-1,573.33%-251K
168.02%268K
737.84%310K
54.55%-160K
196.38%133K
-125.42%-15K
End cash Position
-20.48%17.46M
-20.48%17.46M
-19.57%17.54M
55.34%32.52M
-8.35%19.44M
5.93%21.95M
5.93%21.95M
2.49%21.81M
-1.08%20.93M
-6.40%21.21M
Free cash from
-48.79%7.99M
-14.19%3.19M
-71.82%1.5M
-0.55%2.52M
-80.70%776K
129.61%15.6M
6.26%3.72M
190.89%5.33M
-26.17%2.53M
-29.76%4.02M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -49.31%8M-14.17%3.21M-72.03%1.5M-5.58%2.52M-80.65%778K-6.81%15.79M6.05%3.73M29.29%5.37M-24.03%2.67M-30.18%4.02M
Net income from continuing operations 28.61%-19.66M44.03%-3.02M29.81%-4.84M39.79%-5.68M-5.42%-6.11M-16.67%-27.53M15.99%-5.4M-56.49%-6.9M-3.22%-9.44M-60.18%-5.79M
Operating gains losses ---3.38M--0--0----------------------------
Depreciation and amortization -28.87%22.72M-22.89%5.43M-32.89%5.51M-30.00%5.86M-28.85%5.92M-7.16%31.94M-18.93%7.05M-7.10%8.21M-1.45%8.37M-0.81%8.32M
Asset impairment expenditure --0--0--0--------27.60%3.89M--1.54M--0--------
Unrealized gains and losses of investment securities -81.79%526K101.14%3K-99.11%18K-44.21%318K-66.06%187K223.95%2.89M-210.97%-263K611.34%2.03M181.90%570K137.38%551K
Remuneration paid in stock 400.56%1.62M170.38%423K2,789.47%511K211.68%427K565.45%256K-118.41%-538K-179.92%-601K-115.20%-19K-88.86%137K-106.75%-55K
Deferred tax 647.70%3.81M-44.86%59K91.31%-47K4,642.35%3.86M65.54%-61K-604.35%-696K212.63%107K-176.02%-541K-525.00%-85K-143.28%-177K
Other non cashItems 53.83%1.23M44.70%314K77.39%353K45.79%277K47.64%282K-1.60%797K9.60%217K-0.50%199K-7.32%190K-7.73%191K
Change In working capital -77.35%1.14M-100.46%-5K-99.92%2K46.61%843K-69.38%301K225.60%5.04M554.82%1.09M47,940.00%2.39M61.52%575K-4.56%983K
-Change in receivables 221.14%2.37M998.64%2.43M-207.54%-1.24M120.34%346K-21.33%837K377.44%738K128.96%221K1,168.13%1.15M-183.50%-1.7M5.77%1.06M
-Change in inventory 71.41%-189K-197.88%-1.83M19.41%1.22M70.83%1.19M56.35%-770K-6.27%-661K-149.52%-613K291.37%1.02M138.77%696K-476.92%-1.76M
-Change in payables and accrued expense -294.94%-4.43M-764.78%-3.66M-46.13%842K-286.16%-1.12M-134.86%-495K-27.72%2.27M34.01%-423K901.92%1.56M-107.99%-289K14,100.00%1.42M
-Change in other current assets 123.12%444K-3.48%333K279.35%588K-126.59%-750K810.00%273K217.75%199K131.54%345K-46.37%155K58.10%-331K-83.61%30K
-Change in other working capital 18.19%2.94M74.57%2.72M6.33%-1.41M-46.64%1.17M95.71%456K562.83%2.49M750.82%1.56M-18,650.00%-1.5M2,994.74%2.2M136.58%233K
Cash from discontinued investing activities
Operating cash flow -49.31%8M-14.17%3.21M-72.03%1.5M-5.58%2.52M-80.65%778K-6.81%15.79M6.05%3.73M29.29%5.37M-24.03%2.67M-30.18%4.02M
Investing cash flow
Cash flow from continuing investing activities 6,308.99%11.74M7.14%-13K-3,650.00%-1.5M9,914.81%13.25M-2K98.14%-189K30.00%-14K99.60%-40K-66.67%-135K0
Net PPE purchase and sale 63.41%-15K7.14%-13K--0--0---2K8.89%-41K-55.56%-14K--0-80.00%-27K--0
Net intangibles purchas and sale 9,052.70%13.25M--0--0--------98.54%-148K--099.60%-40K--------
Net business purchase and sale ---1.5M--0--------------0--0------------
Cash from discontinued investing activities
Investing cash flow 6,308.99%11.74M7.14%-13K-3,650.00%-1.5M9,914.81%13.25M---2K98.14%-189K30.00%-14K99.60%-40K-66.67%-135K--0
Financing cash flow
Cash flow from continuing financing activities -59.60%-23.36M31.70%-2.65M-251.81%-15.1M12.48%-2.58M13.66%-3.03M-113.52%-14.64M5.08%-3.89M-167.77%-4.29M38.54%-2.95M18.22%-3.51M
Net issuance payments of debt -127.97%-21.57M19.72%-2.65M-548.45%-15.1M-3.75%-1.61M2.80%-2.22M-2,045.80%-9.46M-29.60%-3.31M-127.55%-2.33M51.35%-1.55M27.76%-2.28M
Net common stock issuance 61.34%-600K--0--0-71.35%-317K-53.80%-283K-55.51%-1.55M-65.71%-580K-123.33%-603K48.18%-185K-776.19%-184K
Cash dividends paid --0--0--0--0--051.67%-2.4M--0--04.03%-1.22M7.80%-1.18M
Proceeds from stock option exercised by employees --0--0--0--0--0-27.17%134K--0--0--0-18.79%134K
Net other financing activities 12.43%-1.19M--0--0---658K---533K-112.83%-1.36M--0------------
Cash from discontinued financing activities
Financing cash flow -59.60%-23.36M31.70%-2.65M-251.81%-15.1M12.48%-2.58M13.66%-3.03M-113.52%-14.64M5.08%-3.89M-167.77%-4.29M38.54%-2.95M18.22%-3.51M
Net cash flow
Beginning cash position 5.93%21.95M-19.57%17.54M55.34%32.52M-8.35%19.44M5.93%21.95M-2.15%20.72M2.49%21.81M-1.08%20.93M-6.40%21.21M-2.15%20.72M
Current changes in cash -477.32%-3.63M424.10%538K-1,557.05%-15.1M3,278.07%13.19M-546.25%-2.26M1,650.00%961K72.01%-166K119.96%1.04M69.62%-415K-64.52%506K
Effect of exchange rate changes -424.63%-870K-300.65%-622K175.00%120K-187.97%-117K-1,573.33%-251K168.02%268K737.84%310K54.55%-160K196.38%133K-125.42%-15K
End cash Position -20.48%17.46M-20.48%17.46M-19.57%17.54M55.34%32.52M-8.35%19.44M5.93%21.95M5.93%21.95M2.49%21.81M-1.08%20.93M-6.40%21.21M
Free cash from -48.79%7.99M-14.19%3.19M-71.82%1.5M-0.55%2.52M-80.70%776K129.61%15.6M6.26%3.72M190.89%5.33M-26.17%2.53M-29.76%4.02M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.